OASIS-C
11/11/2022
Education for clinicians and reviewers on the new OASIS-E items for pain and their intent — as well as the included time frames and the recommended method of obtaining an accurate response — is vital ahead of implementation on Jan. 1.
10/13/2022
Agencies should educate staff now on the significance of the addition of A1110 (Language) to the OASIS-E assessment come Jan. 1, as details could improve care plan compliance and lead to better outcomes.
10/07/2022
Come April 2023, coders may be able to capture more data on social determinants of health, including problems related to health literacy.
07/28/2022
CMS provides easier-to-understand verbiage, the addition of WOCN guidance, new item rationale and definition boxes in its draft OASIS-E Guidance Manual that can help clinicians answer tricky wound questions.
06/15/2022
Find time to train clinicians on the new and revised OASIS-E social determinants of health (SDoH) — including health literacy, transportation, race and ethnicity — and your agency will benefit from better quality outcomes.
06/15/2022
Do not assign E78.5 (Hyperlipidemia, unspecified) for a diagnosis of unspecified hyperlipidemia and hypercholesterolemia as the hypercholesterolemia identifies the specific blood lipid elevated, the Coding Clinic notes in its Q2 2022 guidance update, released June 3.
04/28/2022
Any assistance or transportation required to get medications into the home should not be taken into consideration when answering OASIS items M2020 and M2030, CMS clarified in the quarterly Q&As, released April 19.
03/31/2022
Use occupational therapists more often to evaluate patients’ environments, and you’ll reduce the number of visits that need to be completed and improve the patients’ outcomes.
02/17/2022
When OASIS-E goes into effect on Jan. 1, 2023, agencies will be required to report when and how medication reconciliation occurs when the patient leaves the agency.
01/27/2022
Recent CMS guidance on how to answer M2020 (Management of oral medications) and M2030 (Management of injectable medications) represents a shift from previous guidance.

Login

User Name:
Password: